Adastra Holdings Past Earnings Performance

Past criteria checks 0/6

Adastra Holdings has been growing earnings at an average annual rate of 10.9%, while the Pharmaceuticals industry saw earnings growing at 45.6% annually. Revenues have been growing at an average rate of 56.4% per year.

Key information

10.9%

Earnings growth rate

22.3%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate56.4%
Return on equity-19.5%
Net Margin-10.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower

Oct 23
Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower

Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower

Sep 08
Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower

Is Adastra Holdings (CSE:XTRX) A Risky Investment?

Sep 04
Is Adastra Holdings (CSE:XTRX) A Risky Investment?

Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%

Jul 11
Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%

Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 27%

May 08
Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 27%

Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full Story

Mar 08
Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full Story

Adastra Holdings Ltd.'s (CSE:XTRX) Shares Not Telling The Full Story

Jan 23
Adastra Holdings Ltd.'s (CSE:XTRX) Shares Not Telling The Full Story

Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

Sep 28
Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

Subdued Growth No Barrier To Adastra Holdings Ltd.'s (CSE:XTRX) Price

Aug 03
Subdued Growth No Barrier To Adastra Holdings Ltd.'s (CSE:XTRX) Price

Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

Jan 13
Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

We Think Adastra Holdings (CSE:XTRX) Has A Fair Chunk Of Debt

Sep 28
We Think Adastra Holdings (CSE:XTRX) Has A Fair Chunk Of Debt

Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

Mar 23
Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

Dec 07
Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

Here's Why Phyto Extractions (CSE:XTRX) Can Afford Some Debt

Aug 18
Here's Why Phyto Extractions (CSE:XTRX) Can Afford Some Debt

Auditors Have Doubts About Phyto Extractions (CSE:XTRX)

May 04
Auditors Have Doubts About Phyto Extractions (CSE:XTRX)

Adastra Labs Holdings (CSE:XTRX) Is Making Moderate Use Of Debt

Dec 10
Adastra Labs Holdings (CSE:XTRX) Is Making Moderate Use Of Debt

Revenue & Expenses Breakdown

How Adastra Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:XTRX Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2425-390
30 Jun 2423-390
31 Mar 2423-5100
31 Dec 2322-490
30 Sep 2321-590
30 Jun 2321-580
31 Mar 2317-470
31 Dec 2213-460
30 Sep 2211-370
30 Jun 229-360
31 Mar 227-350
31 Dec 216-340
30 Sep 215-120
30 Jun 214-550
31 Mar 213-550
31 Dec 202-880
30 Sep 201-1180
30 Jun 200-750
31 Mar 200-740
31 Dec 190-420
31 Oct 190-210
31 Jul 190-110

Quality Earnings: XTRX is currently unprofitable.

Growing Profit Margin: XTRX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: XTRX is unprofitable, but has reduced losses over the past 5 years at a rate of 10.9% per year.

Accelerating Growth: Unable to compare XTRX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: XTRX is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-51.1%).


Return on Equity

High ROE: XTRX has a negative Return on Equity (-19.46%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:30
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Adastra Holdings Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution